baber/WOPTO huggingface dataset:
Patent SI-2576704-T1 (SI)
Title: Process for manufacturing high solids suspensions of mineral materials
Inventor: BURI MATTHIAS
IPC: C09D7/45
Filed: 2011-05-26
Abstract: The present invention relates to a process for manufacturing high solids aqueous suspensions of mineral materials comprising the steps of providing at least one mineral material, preparing an aqueous suspension comprising the at least one mineral material, grinding the resulting aqueous suspension, centrifuging the ground aqueous suspension, and concentrating the centrifuged product of step d) by flash cooling; the high solids aqueous suspension of mineral materials obtained by this process, as well as the use thereof.
Patent DE-3586837-T2 (DE)
Inventor: PEARCE HOWARD R
IPC: H01R43/055
Filed: 1985-08-07
Granted: 1993-05-19
Abstract: A bandolier assembly is provided for use in an apparatus for assemblying a two-part electrical connector with an interposed cable. The bandolier, which is elongate, supports a plurality of pre-assembled connectors (13) in longitudinally spaced envelopes (40) in preparation for crimping of the connector (13) and an interposed cable.
Patent DE-3687456-T2 (DE)
Inventor: BELLOWS RICHARD JAMES
IPC: H01M10/36
Filed: 1986-10-30
Granted: 1993-04-29
Abstract: A metal halogen cell (l2) has a metal anode (l0) and a chemically inert electrode (l6), both disposed in an electrolyte (l4). The electrolyte (l4) is an aqueous metal halide solution, the metal correspondponders to anode (l0) and the halide to the halogen generated at electrode (l6). cell (l2) is divided into anolyte and catholyte portions by a microporous separator (l8), which is of a material which is not wetted by cathodic halogen and is preferably wetted by the aqueous electrolyte.
Patent DE-3879650-T2 (DE)
Inventor: WROBEL JAY E
IPC: A61K31/195
Filed: 1988-12-23
Granted: 1993-07-01
Abstract: Disclosed herein are N-acyl-N-naphthoylglycines, methods for their preparation and intermediates used therein. The N-acyl-N-naphthoylglycines are novel aldose reductase inhibitors useful for the treatment or prevention of diabetic complications and have the formula: <CHEM>  wherein R<1> is fluorine, chlorine, bromine or trifluoroethoxy; R<2> is lower alkyl containing 1 to 3 carbon atoms; X is -OH or -NH2 and the pharmaceutically acceptable salts thereof wherein X is -OH.
Patent DE-3889956-T2 (DE)
Inventor: FRITZBERG ALAN R
IPC: C07F7/24
Filed: 1988-03-24
Granted: 1994-12-22
Abstract: Chelated radionuclide compositions are provided for conjugation to polypeptides and carbohydrates. The resulting conjugates may be used in diagnosis and therapy.
Patent TR-199801655-T2 (TR)
Inventor: BACON DENNIS RAY
IPC: C11D3/50
Filed: 1997-02-19
Abstract: Etkisi uzun süre kalici olan parfüm bilesimleri içeren bir deterjan bilesimi saglanmaktadir. Özel olarak bu deterjan bilesimi, yaklasik olarak en az %70 kadari kalici parfüm bilesenlerinden meydana gelen bir parfüm bilesimi içermektedir. Söz konusu parfüm esas olarak halojenli koku maddeleri ve nitromisk ihtiva etmemektedir. Bilesim ayrica yaklasik olarak %0.01-95 arasinda bir deterjan surfaktan sistemi içermekte olup bu sistem tercihan anyonik ve/veya iyonik olmayan deterjan surfaktanlarindan olusmaktadir. Bilesimler granül, sivi, macun, çubuk, vb. biçiminde olabilmektedir.
Patent TR-199902752-T2 (TR)
Inventor: MARQUIS ROBERT W
IPC: A61K38/00
Filed: 1998-05-06
Abstract: Bu bulus, cysteine proteazlari inhibitörleri, özellikle kathepsin K inhibitörü olan ve kemik kaybi inhibisyonun bir faktör oldugu hastaliklarin tedavisinde kullanilan, Y' nin Ar veya NR1R2; R1' in R",R"C(O),R"C(S), R"SO2, R"R'NC(O), veya R3' ün H, C2-6alkenil, C2-6alkenil Het, Ar veya SR', NR'2, N'(R)C(O)OR", CO2R', CO2NR'2, N(C=NH)NH2, Het veya Ar ile tercihe göre ikameli olan C1-6 alkil; R4' ün H, C1-6 alkil, C2-6alkenil, Ar- C0-6alkil, veya Het- C0-6alkil; R5(a), Ar-C0-6alkil, Het-C0-6alkil, adamantil-C(O)-, Ar-C(O)-, Het-C(O)-; R6' nin R"OC(O)NR'CH(R*)C(O); R7' nin C3-6sikloalkil- C0-6alkil, Ar- C0-6alkil, Het-C0-6alkil, Ar-C0-6alkoksi, Het- C0-6alkoksi veya OR', SR', NR'2, N(R')C(O)OR", CO2R', ', CO2NR'2, N(C=NH)NH2, Het- C0-6 alkil; her bir R' nin ayri ayri H, C1-6 alkil, C2-6 alkenil, Ar- C0-6alkil veya Het- C0-6alkil. Veya Her biri R" nin ayri ayri C1-6 alkil, C3-6sikloalkil- C0-6alkil, Ar- C0-6alkil veya Het- C0-6alkil; R"' nin H, C1-6alkil, DEVAMI VAR.
Patent DE-60001121-T2 (DE)
Inventor: TAKAHASHI HIROSHI
IPC: C09D11/38
Filed: 2000-02-02
Granted: 2003-06-05
Abstract: An additive for inkjet printing, comprising a stabilized ascorbic acid derivative. Also disclosed are a recording solution, a method for preventing discoloration and fading of an image, and a recording sheet, each using the additive. The color change of an image can be prevented by incorporating the stabilized ascorbic acid derivative into an inkjet-printed image.
Patent DE-60001182-T2 (DE)
Inventor: DENIS ALEXIS
IPC: A61K31/7048
Filed: 2000-02-03
Granted: 2003-10-09
Abstract: Erythromycin derivatives (I) are new.  Erythromycin derivatives of formula (I) and their acid addition salts are new.  X = CH2 or NH;  n = 1-8;  Y' = H or halo;  R = a heterocycle of formula (i)-(iii);  W' = H, halo, 1-8C alkyl optionally substituted by at least one halo;  Z = H or an acid residue.  Independent claims are also included for: (1) intermediates of formula R(CH2)n-XNH2 (III), especially those in which n = 3 and X = methylene; and  (2) the preparation of (I).
Patent DE-60006210-T2 (DE)
Inventor: AL-AKHDAR WALID
IPC: C08F2/48
Filed: 2000-11-29
Granted: 2004-07-15
Abstract: The present invention relates to a novel photoinitiator system comprising one or more acylphosphine oxide photoinitiators and one or more lightfast red, blue or violet organic pigments. Low yellow color formation results upon curing ethylenically unsaturated compounds with the new photoinitiator system. Particular applications include clear and white coatings, screen inks, gel coats, powder coatings, composites, adhesives and lenses.
Patent DE-60007783-T2 (DE)
Inventor: SCHER BENSON
IPC: A01N25/00
Filed: 2000-06-13
Granted: 2004-12-02
Abstract: A method of selectively controlling undesirable vegetation in crops by using a postemergent application of an herbicidally effective amount of a metal chelate of a 2-(substituted benzoyl)-1,3-cyclohexanedione compound to the locus of such undesirable vegetation.
Patent DE-60009059-T2 (DE)
Inventor: RACCANELLO GIANCARLO
IPC: H01R13/58
Filed: 2000-04-27
Granted: 2004-11-25
Abstract: A device is described, for the screened connection of at least a screened cable (4), in particular a coaxial cable, comprising at least two conductors (4A, 4C) for carrying video and/or audio and/or data signals, said device comprising a body (2) to which a connection element (7) is associated, being in contact with said cable (4) and capable of movement with respect to said body (2), where fixing means (5, 6) are provided for locking said connection element (7) to said body (2). According to the invention, following a movement of said connection element (7) with respect to said body (2), in particular imparted through said fixing means (5, 6), said connection element (7) is capable of changing its own configuration with respect to said cable (4), in order to obtain a mechanical and/or electric coupling between said cable (4) and said connection element (7).
Patent DE-60009269-T2 (DE)
Inventor: VEAS FRANCISCO
IPC: A61K35/14
Filed: 2000-02-15
Granted: 2005-02-24
Abstract: The invention concerns immunogenic compositions prepared from preparations obtained by incubating first means expressing the target receptor(s) of an infectious pathogenic agent, with second means expressing at least the regions of the infectious pathogenic agent recognising said targets, in conditions enabling interaction between the first and second means so as to form a complex, the incubation being carried out according to different time intervals; and contacting the resulting complexes with a binding agent, for different time intervals, said first and second means being tolerated by mammals. The invention is useful for preparing vaccine compositions designed for mammals against an infectious pathology.
Patent DE-60009652-T2 (DE)
Inventor: EINIG HEINZ
IPC: A61K31/52
Filed: 2000-01-07
Granted: 2005-03-24
Abstract: A pharmaceutical mixture comprising a profen and one or more additional active compounds is described which has a total active compound content of over 85% and contains up to 1%, based on the content of the profen, of a nonionic surfactant having an HLB of >=9 and a customary disintegrant and a lubricant.
Patent DE-60010643-T2 (DE)
Inventor: WEIBEL NICOLAS DENIS
IPC: B29C35/16
Filed: 2000-01-21
Granted: 2005-05-19
Abstract: In a moulding process, in particular in a bladder inflation moulding (BIM process) a thin walled mould is machined to the exact shape of the part to avoid any post machining of the part after stripping. The heating is performed in a liquid tin bath, used to dip the mould therein for fast heat transfer. Processing cycle times of less than 1 minute are reached. <IMAGE>
Patent DE-60012165-T2 (DE)
Inventor: LIDOR-HADAS RAMY
IPC: A61K31/66
Filed: 2000-02-11
Granted: 2005-08-25
Abstract: A novel process for the preparation of alendronic acid is disclosed. The method comprises the steps of reacting a compound of formula I with H3PO3wherein R is an imido group and R1 is selected from the group consisting of chloro, bromo, iodo, fluoro, hydroxy, amino, -OR2 or -OC(O)R2, wherein R2 is C1-C12 alkyl, C1-C12 cycloalkyl or C1-C12 aryl; and then reacting the product of the first step with a deprotecting agent. Alendronic acid is then recovered. The method is safe, efficient and suitable for use on a large scale.
Patent DE-60015941-T2 (DE)
Inventor: TAKEUCHI HIROSHI
IPC: A47C20/04
Filed: 2000-07-14
Granted: 2006-02-09
Abstract: A bed base structure (1) for an adjustable bed includes at least one flexible portion (9) comprising a plurality of elongate support strips (20) connected together along juxtaposed parallel faces thereof, each strip (20) having at least one projection (21) and/or at least one recess for interengagement with a corresponding recess (22) and/or projection on the facing face of the adjacent strip, and is characterised in that the shapes of the projection and recess are such that the interconnection of two adjacent strips thereby, allows both relative turning and relative separation and approach movements of one strip with respect to the other, and in that there are provided means (24) for preventing disengagement of the said projection from the said recess, whereby to allow the bed base structure to be adjusted to include curved portions for supporting curved parts of the body of a user. <IMAGE>
Patent DE-60017579-T2 (DE)
Inventor: COCCHINI FRANCO
IPC: B29C48/05
Filed: 2000-10-18
Granted: 2006-03-23
Abstract: A method of measuring the twist imparted to an optical fibre includes the steps of advancing the optical fibre in a predetermined direction and at a predetermined velocity, imparting to the optical fibre, during the step of advancing, a twist about its axis, measuring the diameter of the optical fibre during the step of advancing, to generate a time-based signal indicating the diameter, and processing this signal to find a value indicating the imparted twist. The step of processing includes the principal steps of transforming in the frequency domain the signal relating to the measurement of the diameter, calculating the power spectrum of the signal thus obtained, distinguishing in this power spectrum the signal peaks correlated with the imparted twist, determining the maximum frequency associated with these signal peaks, and dividing the value of this maximum frequency by the value of the velocity of advance of the fibre to find the value indicating the imparted twist.
Patent DE-60018592-T2 (DE)
Inventor: BOULTON GARY
IPC: F16F15/02
Filed: 2000-05-12
Granted: 2006-01-12
Abstract: Vibration damping apparatus (40) includes a body in the form of backup roll balance piston (42) positionable for sliding movement in an enclosure in the form of cavity (44) in the lower backup roll chock (30) of the mill stack (10). The body of the piston is a casing which performs the role of a conventional postion. A damping means is integral with the piston (42) for providing vibration damping of opposing backup roll chocks (24, 30). The damping means is a specially designed absorption system to provide tuned stiffness and damping elements which act in parallel and are located in compartment (46) at an uppermost end or cap of the piston (42). A second vibration absorbent compartment portion (56) of the piston (42) also includes vibration absorbing components. Portion (56) is an integral cap located at the end of the piston (42) in contact with the fluid (52).
Patent DE-60024785-T2 (DE)
Inventor: LEE JEEWOO
IPC: C07C235/34
Filed: 2000-02-21
Granted: 2006-09-14
Abstract: The present invention is related to new vanilloid analogues containing resiniferatoxin pharmacophores, pharmaceutical compositions comprising such analogues, and their uses as vanilloid receptor agonists and potent analgesics. The present invention provides a pharmaceutical composition for treating acute, chronic, inflammatory or neuropathic pains or for treating bladder hypersensitivity.
Patent DE-60032793-T2 (DE)
Inventor: D EVELYN PHILIP
IPC: C01G15/00
Filed: 2000-09-28
Granted: 2007-11-08
Abstract: A gallium nitride growth process forms crystalline gallium nitride. The process comprises the steps of providing a source gallium nitride; providing mineralizer; providing solvent; providing a capsule; disposing the source gallium nitride, mineralizer and solvent in the capsule; sealing the capsule; disposing the capsule in a pressure cell; and subjecting the pressure cell to high pressure and high temperature (HPHT) conditions for a length of time sufficient to dissolve the source gallium nitride and precipitate the source gallium nitride into at least one gallium nitride crystal. The invention also provides for gallium nitride crystals formed by the processes of the invention.
Patent DE-60035412-T2 (DE)
Inventor: FINDEIS MARK A
IPC: A61P25/28
Filed: 2000-03-03
Granted: 2008-02-14
Abstract: Compounds that modulate natural β amyloid peptide aggregation are provided. The modulators of the invention comprise a peptide, preferably based on a β amyloid peptide, that is comprised entirely of D-amino acids. Preferably, the peptide comprises 3-5 D-amino acid residues and includes at least two D-amino acid residues independently selected from the group consisting of D-leucine, D-phenylalanine and D-valine. In a particularly preferred embodiment, the peptide is a retro-inverso isomer of a β amyloid peptide, preferably a retro-inverso isomer of Aβ17-21. In certain embodiments, the peptide is modified at the amino-terminus, the carboxy-terminus, or both. Preferred amino-terminal modifying groups alkyl groups. Preferred carboxy-terminal modifying groups include an amide group, an acetate group, an alkyl amide group, an aryl amide group or a hydroxy group. Pharmaceutical compositions comprising the compounds of the invention, and diagnostic and treatment methods for amyloidogenic diseases using the compounds of the invention, are also disclosed.
Patent DE-60100055-T2 (DE)
Inventor: SELVE DR
IPC: A61P25/04
Filed: 2001-03-21
Granted: 2003-07-24
Abstract: The present invention concerns the use of peptidic compounds for the preparation of a pharmaceutical composition for the treatment of diabetic neuropathic pain.
Patent DE-60106580-T2 (DE)
Inventor: ROSSI PIERRE
IPC: C04B20/00
Filed: 2001-03-09
Granted: 2006-02-16
Abstract: The invention relates to a fiber/cement composite, the cementitious matrix of which has a water/binder ratio of less than 0.25 and consisting of cement, aggregate elements, fine pozzolanic elements and a plasticizer.The reinforcement consists of three types of fiber: a) metal fibers having a length of between 15 and 25 mm and a diameter of between 0.25 and 0.3 mm, in a percentage by volume of between 0.5 and 3%; b) metal fibers having a length of between 5 and 10 mm and a diameter of between 0.15 and 0.2 mm, in a percentage of between 4 and 7%; and c) 1.5 to 5% of short metal fibers having a length of less than 3 mm.The strength of this composite in uniaxial tension is greater than or equal to 30 MPa. It exhibits positive work-hardening and ductile behavior in uniaxial tension.
Patent DE-60112162-T2 (DE)
Inventor: GIGNOUX PIERRE
IPC: A63C10/10
Filed: 2001-04-12
Granted: 2006-04-20
Abstract: The snowboard boot fixing comprises a jaw (61) which pivots about a horizontal spindle (62) and has a cam shaped part (65). The jaw is locked in its lowered position by a finger (67) which moves in a guide (69). The fixing is fitted with an indicator (76) which indicates if the jaw is in the locked position.
Patent DE-60114605-T2 (DE)
Inventor: RYAN BERNARD
IPC: C09J5/04
Filed: 2001-05-11
Granted: 2006-07-27
Abstract: An activator composition for the accelerated hardening of cyanoacrylate adhesives, wherein the activator comprises a member selected from the group consisting of: aromatic heterocyclic compounds having at least one N hetero atom in the ring(s) such as pyridines, quinolines and pyrimidines and substituted on the ring(s) with at least one electron-withdrawing group which decreases the base strength of the substituted compound compared to the corresponding unsubstituted compound, mixtures of any of the foregoing with each other, and/or with N,N-dimethyl-p-toluidine, and mixtures of any of the foregoing and/or N,N-dimethyl-p-toluidine with an organic compound containing the structural element, -N=C-S-S-, such as dibenzothiazyl disulfide, 6,6'dithiodinicotinic acid, 2,2'dipyridyl disulfide, and bis(4-t-butyl-1-isopropyl-2-imidazolyl) disulfide. An activator composition may comprise a solution of one or more activators in a solvent mixture which comprises a volatile hydrocarbon and a cyclic ketone.
Patent DE-60115070-T2 (DE)
Inventor: YEW NELSON
IPC: A61K48/00
Filed: 2001-09-13
Granted: 2006-07-27
Abstract: Sustained transgene expression will be required for the vast majority of genetic diseases being considered for gene therapy. The initially high levels of expression attained with plasmid DNA (pDNA) vectors containing viral promoters, such as that from cytomegalovirus (CMV), decline precipitously to near background levels within 2 to 3 weeks. We have constructed pDNA vectors containing the human cellular ubiquitin B (Ub) promoter and evaluated their expression in the mouse lung. Cationic lipid-pDNA complexes were instilled intranasally (IN) or injected intravenously (IV) into immunodeficient BALB/c mice. Chloramphenicol acetyltransferase (CAT) reporter gene expression from the Ub promoter was initially very low at day 2 post-administration but by day 35 exceeded the level of expression attained from a CMV promoter vector by 4- to 9-fold. Appending a portion of the CMV enhancer 5' of the Ub promoter (CMV-Ub) increased CAT expression to nearly that of the CMV promoter and expression persisted in the lung for at least three months, with 50% of day 2 levels remaining at day 84. In the liver, expression from the CMV-Ub hybrid promoter was sustained for 42 days. Since previous studies have shown that eliminating immunostimulatory CpG motifs in pDNA vectors reduces their toxicity, we constructed a CpG deficient version of the CMV-Ub vector expressing alpha-galactosidase A, the enzyme that is deficient in Fabry disease, a lysosomal storage disorder. After IN or IV administration, levels of alpha-galactosidase A from this vector were not only undiminished but increased 500% to 1500% by day 35. These results suggest that CpG-reduced plasmid vectors containing a CMV-Ub hybrid promoter may provide the long-term expression and efficacy required for a practical gene therapeutic.
Patent DE-60115871-T2 (DE)
Inventor: BLANCHARD DANIEL
IPC: B29C65/00
Filed: 2001-04-05
Granted: 2006-08-10
Abstract: The invention concerns an ultrasonic device for sealing at least two superimposed sheets, said device comprising a sealing assembly consisting of two elements which are respectively an anvil and a sonotrode, arranged opposite each other so that their facing surfaces form an interstice for passing through the sheets to be sealed, said interstice having an inlet section and an outlet section, the sonotrode vibrating at high frequencies to emit ultrasonic waves, characterised in that means are provided for generating between the superimposed sheets and said sealing assembly a relative movement along a specific feeding direction relative to the sealing assembly, and the section of said passage interstice decreases between its inlet section and its outlet section, and at least one element of said sealing assembly comprises a projecting ridge emerging into said passage interstice and extending along a direction globally parallel to said feeding direction. The invention also concerns a related method for sealing flexible packages, and the resulting packages.
Patent DE-60119390-T2 (DE)
Inventor: SALOTTO MICAELA
IPC: A41D27/24
Filed: 2001-11-07
Granted: 2007-04-19
Abstract: The present invention relates to a method for making underpants, panties and the like, comprising the steps of providing a semi-fished article of manufacture comprising a flat layer of an elasticized fabric, overlapping, at the edge ends, a plastics material finishing strip and joining to one another the cross portions arranged at the opposite base edges to provide an underpants or the like article.
Patent DE-60120224-T2 (DE)
Inventor: AMARK MIKAEL
IPC: A61M5/20
Filed: 2001-12-14
Granted: 2007-03-29
Abstract: A device for auto-injection of a dose of medicament, comprises a housing arranged to contain a medicament container therein and a contact part intended to be applied against an injection site, a needle cover surrounding a needle arranged to the medicament container and extending at least the length of the needle, spring elements for, upon activation, pushing the needle past the end of the cover as well as operating the medicament container to supply the dose of medicament, first locking elements for locking the spring elements in a pressurized state, first activating elements for, upon manual operation, releasing the spring elements for injection. There is a second locking element capable of locking the first activating element and a second activating element, capable of releasing the second locking element when the contact part is exposed to pressure.
Patent DE-60123178-T2 (DE)
Inventor: SASAKI YASUSHI
IPC: H01L23/495
Filed: 2001-07-11
Granted: 2007-10-25
Abstract: There is provided a semiconductor device composed of lead frame (13) in which the possibility of a complicated manufacturing process is prevented and a reduction in manufacturing cost can be satisfactorily achieved. <??>In such a semiconductor device, a lead frame (13) is adhered to a base substrate (15) for heat dissipation via an insulating layer (18) and an outward guided terminal portion (17) is formed by perpendicularly upwardly bending an end of the lead frame after the mounting of one or more of power semiconductor elements on the lead frame, a portion (130) having a recess formed thereon is formed beforehand in a portion of the lead frame to be bent, and it is ensured that the lead frame does not adhere to the surface of the base substrate in this portion (130) formed with recess thereon when the lead frame is adhered to the base substrate via the insulating layer (18) before the bending of the lead frame. <IMAGE>
Patent DE-60123579-T2 (DE)
Inventor: FLEMING PAUL
IPC: C07B61/00
Filed: 2001-01-26
Granted: 2007-06-21
Abstract: The present invention relates to a novel process for producing a delta-lactone of the formula:using an acyl halide of the formula:wherein R<1>, R<2 >R<3 >and X are described herein, as well as novel intermediates. In particular, the present invention relates to a process for enantioselectively producing the (R)-delta-lactone.